1. Treating head and neck tumors during the SARS-CoV-2 epidemic, 2019 to 2020: Sichuan Cancer Hospital.
- Author
-
Cai YC, Wang W, Li C, Zeng DF, Zhou YQ, Sun RH, Jiang H, Guo H, Wang SX, and Jiang J
- Subjects
- Betacoronavirus, COVID-19, China, Communicable Disease Control organization & administration, Coronavirus Infections prevention & control, Emergencies epidemiology, Emergency Service, Hospital organization & administration, Female, Head and Neck Neoplasms diagnosis, Head and Neck Neoplasms epidemiology, Hospitals, Special organization & administration, Humans, Male, Pandemics prevention & control, Patient Safety, Pneumonia, Viral prevention & control, SARS-CoV-2, Triage, Cancer Care Facilities organization & administration, Communicable Diseases transmission, Coronavirus Infections epidemiology, Delivery of Health Care organization & administration, Head and Neck Neoplasms therapy, Pneumonia, Viral epidemiology
- Abstract
Since December 2019, a number of patients with novel coronavirus pneumonia (NCP) have been identified in Wuhan, Hubei Province, China. NCP has rapidly spread to other provinces and cities in China and other countries in the world. Due to the rapid increase in reported cases in China and around the world, on January 30, 2020, the World Health Organization (WHO) Emergency Committee announced that NCP is a Public Health Emergency of International Concern (PHEIC). However, there are relatively few suggestions and measures for tumor patients, especially patients with head and neck tumors. This article summarizes the prevention and control of disease in our medical institution to provide a reference for front-line head and neck surgeons., (© 2020 The Authors. Head & Neck published by Wiley Periodicals, Inc.)
- Published
- 2020
- Full Text
- View/download PDF